<code id='FC381D25C8'></code><style id='FC381D25C8'></style>
    • <acronym id='FC381D25C8'></acronym>
      <center id='FC381D25C8'><center id='FC381D25C8'><tfoot id='FC381D25C8'></tfoot></center><abbr id='FC381D25C8'><dir id='FC381D25C8'><tfoot id='FC381D25C8'></tfoot><noframes id='FC381D25C8'>

    • <optgroup id='FC381D25C8'><strike id='FC381D25C8'><sup id='FC381D25C8'></sup></strike><code id='FC381D25C8'></code></optgroup>
        1. <b id='FC381D25C8'><label id='FC381D25C8'><select id='FC381D25C8'><dt id='FC381D25C8'><span id='FC381D25C8'></span></dt></select></label></b><u id='FC381D25C8'></u>
          <i id='FC381D25C8'><strike id='FC381D25C8'><tt id='FC381D25C8'><pre id='FC381D25C8'></pre></tt></strike></i>

          entertainment

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

          GwenPetersen,38,anALSpatient,believesthattherecentfailureofAmylyx'sdrugRelyvriocouldstillteachresear

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Readout LOUD podcast: ALS dilemma, first MASH drug, and more

          Whathappenswhenanapproveddrugdoesn’twork?Whydon’tpatientswantgenetherapy?AndisMASHstillabigdeal?Weco